Filing Details
- Accession Number:
- 0000885590-14-000030
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-03-25 13:06:32
- Reporting Period:
- 2014-03-21
- Filing Date:
- 2014-03-25
- Accepted Time:
- 2014-03-25 13:06:32
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
885590 | Valeant Pharmaceuticals International Inc. | VRX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1387813 | Laizer Kornwasser | 2150 St. Elzear Blvd. West Laval A8 H7L 4A8 | Evp, Company Group Chairman | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, No Par Value | Acquisiton | 2014-03-21 | 2,481 | $134.97 | 53,582 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- This number represents the weighted average purchase price for all purchases of common stock purchased by the reporting officer pursuant to a 10b5-1 trading plan.